Delivery Order SPE2DB22D3501-SPE2DB24FUV82
Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $7.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The $2,181.63 contract has an ultimate completion date of December 5, 2022 and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceuticals and medical supplies to support military...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,476.44, is for the delivery of Cyclosporine 0.05% eye emulsion in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on September 20, 2023. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant...
- This is a $34,050.15 firm fixed-price delivery order for cyclosporine 0.05% eye emulsion awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses critical medical commodities...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,647.00, is for the delivery of Cyclosporine 0.05% eye emulsion. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract was not set aside and was awarded through open competition. AmerisourceBergen holds a significant $999,999,999...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,912.87 firm fixed-price contract is for the supply of Cyclosporine 0.05% eye emulsion to support military healthcare programs. The contract has an ultimate completion date of January 18, 2024. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,508.85 fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a prescription drug used to treat certain eye conditions. The contract has a period of performance through June 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation is for the delivery of Cyclosporine 0.05% Eye Emulsion in 60 count packages. The $2,718.30 firm fixed price Delivery Order has an ultimate completion date of August 16, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,535.06 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion. The contract has an ultimate completion date of June 27, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,086.11, is for the supply of CYCLOSPORINE 0.05% EYE EMULSION medical product with an ultimate completion date of January 22, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. AmerisourceBergen holds a significant...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Cyclosporine 0.05% eye emulsion to the government. The $7,560.22 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 3, 2025, with a completion date of January 6, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...